Treatment Time or Convection Volume in HDF: What Drives the Reduced Mortality Risk?

C.L.M. de Roij van Zuijdewijn, M.J. Nube, P.M. ter Wee, P.J. Blankestijn, R. Levesque, M.A. van den Dorpel, M.L. Bots, M.P.C. Grooteman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)53-58
JournalBlood Purification
Volume40
Issue number1
DOIs
Publication statusPublished - 2015

Cite this

@article{243dca4292b1466e869a8c13772889e9,
title = "Treatment Time or Convection Volume in HDF: What Drives the Reduced Mortality Risk?",
author = "{de Roij van Zuijdewijn}, C.L.M. and M.J. Nube and {ter Wee}, P.M. and P.J. Blankestijn and R. Levesque and {van den Dorpel}, M.A. and M.L. Bots and M.P.C. Grooteman",
year = "2015",
doi = "10.1159/000430903",
language = "Undefined/Unknown",
volume = "40",
pages = "53--58",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "1",

}

Treatment Time or Convection Volume in HDF: What Drives the Reduced Mortality Risk? / de Roij van Zuijdewijn, C.L.M.; Nube, M.J.; ter Wee, P.M.; Blankestijn, P.J.; Levesque, R.; van den Dorpel, M.A.; Bots, M.L.; Grooteman, M.P.C.

In: Blood Purification, Vol. 40, No. 1, 2015, p. 53-58.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Treatment Time or Convection Volume in HDF: What Drives the Reduced Mortality Risk?

AU - de Roij van Zuijdewijn, C.L.M.

AU - Nube, M.J.

AU - ter Wee, P.M.

AU - Blankestijn, P.J.

AU - Levesque, R.

AU - van den Dorpel, M.A.

AU - Bots, M.L.

AU - Grooteman, M.P.C.

PY - 2015

Y1 - 2015

U2 - 10.1159/000430903

DO - 10.1159/000430903

M3 - Article

VL - 40

SP - 53

EP - 58

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 1

ER -